E
Lyell Immunopharma, Inc. LYEL
$10.76 -$0.21-1.91% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 8.00K 7.00K 11.00K 34.00K 13.00K
Total Other Revenue -- -- -- -- --
Total Revenue 8.00K 7.00K 11.00K 34.00K 13.00K
Cost of Revenue -- -- -- -- --
Gross Profit 8.00K 7.00K 11.00K 34.00K 13.00K
SG&A Expenses 9.79M 14.05M 14.52M 11.77M 12.26M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -1.34M -1.41M -1.44M -730.00K -976.00K
Total Operating Expenses 43.31M 56.08M 61.75M 50.54M 51.54M
Operating Income -43.30M -56.08M -61.74M -50.51M -51.53M
Income Before Tax -42.68M -52.20M -191.94M -44.58M -45.81M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -42.68M -52.20M -191.94M -44.58M -45.81M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -42.68M -52.20M -191.94M -44.58M -45.81M
EBIT -43.30M -56.08M -61.74M -50.51M -51.53M
EBITDA -40.16M -52.64M -56.72M -45.83M -46.63M
EPS Basic -2.89 -3.54 -13.71 -3.48 -3.59
Normalized Basic EPS -1.64 -2.16 -2.51 -2.17 -2.24
EPS Diluted -2.89 -3.54 -13.71 -3.48 -3.59
Normalized Diluted EPS -1.64 -2.16 -2.51 -2.17 -2.24
Average Basic Shares Outstanding 14.79M 14.75M 14.00M 12.82M 12.77M
Average Diluted Shares Outstanding 14.79M 14.75M 14.00M 12.82M 12.77M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --